Navigation Links
Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
Date:10/5/2010

tibodies for metastatic colorectal cancer (mCRC)(Abstract Number 612P; Poster Discussion; Sunday, Oct. 10, 12:30 p.m. CET, Hall 3)Neulasta® (pegfilgrastim)
  • Granulocyte colony stimulating factor (G-CSF) prophylaxis and febrile neutropenia (FN) incidence in patients with solid tumours receiving myelotoxic chemotherapy who are assessed as high risk for FN: IMPACT SOLID study (Abstract Number 1238PD; Poster Discussion; Saturday, Oct. 9, 1:15 p.m. CET, Yellow 3)


  • Administration of granulocyte-colony stimulating factors (G-CSF) in solid tumors. An Italian observational study by the OBSERVE study group (Abstract Number 1256P; Poster; Sunday, Oct. 10, 12:30-1:30 p.m. CET, Hall 3)Aranesp® (darbepoetin alfa)

  • Darbepoetin alfa dosing weekly and every three weeks in cancer patients with chemotherapy-induced anaemia – efficacy data from the CHOICE study (Abstract Number 1267P; Poster; Sunday, Oct. 10, 12:30-1:30 p.m. CET, Hall 3)


  • Anemia and darbepoetin alfa administration in patients treated with CHOP+/-R chemotherapy: results from an observational study of patients with non-Hodgkin lymphoma(Abstract Number 1270P; Poster; Sunday, Oct. 10, 12:30-1:30 p.m. CET, Hall 3)


  • Darbepoetin alfa in the treatment of chemotherapy-induced anaemia; effects of target haemoglobin label change: data from the APRIORI study (Abstract Number 1268P; Poster; Sunday, Oct. 10, 12:30-1:30 p.m. CET, Hall 3)For the latest updates on Amgen's presence at the ESMO Congress and other Amgen news, follow us on Twitter: @Amgen.About Denosumab and Amgen's Research in Bone BiologyDenosumab is the first fully human monoclonal antibody in late stage clinical development that specifically targets RANK Ligand, the essential regulator of osteoclasts (the cells that break down bone). The denosumab development program is the
    '/>"/>


  • SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
    2. Medarex to Receive Milestone Payment from Amgen
    3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
    4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
    5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
    6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
    7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
    8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
    9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
    10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
    11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... WORTH, Texas , December 18, 2014 /PRNewswire/ ... a networked software application/module that is used to ... related images. RIS comprises a patient tracking and ... system. The integration of RIS with HIS and ... used for patient registration and patient scheduling, patient ...
    (Date:12/19/2014)... REDWOOD CITY, Calif., Dec. 18, 2014 ... on the development of medical diagnostics based on ... of gas flow, today announced financial results for ... 30, 2014. "Following the completion of ... well positioned to maximize the recently initiated CoSense® ...
    (Date:12/19/2014)... , Dec. 19, 2014  Eli Lilly and ... Paris: FR0011184241 – ADOC) today announced a worldwide licensing ... BioChaperone Lispro, for treatment in people with type 1 ... proprietary BioChaperone® technology and is currently in Phase Ib ... Lispro with the goal of optimizing glucose levels during ...
    Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3
    ... , MORRISTOWN, N.J. , May 24 Watson ... subsidiary, Watson Laboratories, Inc., has received approval from the United States ... for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg ... to begin shipping the product shortly.   , ...
    ... Genzyme Corp. has signed a consent decree agreeing to correct manufacturing quality violations at ... government $175 million in unlawful profits from the sale of products that ... , , ... , , ...
    Cached Medicine Technology:Watson's Generic VALTREX® 500 mg and 1000 mg Receives FDA Approval 2Watson's Generic VALTREX® 500 mg and 1000 mg Receives FDA Approval 3Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 2Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 3
    (Date:12/21/2014)... Portland, OR (PRWEB) December 21, 2014 ... discussing some of the issues and systemic barriers for ... ITU World Paratriathlon Champion. Scheidies has a condition called ... over time. He describes how he adapted his athletic ... to use his success in triathlon to pioneer the ...
    (Date:12/21/2014)... OH (PRWEB) December 21, 2014 As ... men alleging heart attacks, stroke and blood clots from ... to increase, a new study shows that the male ... colon cancer. In a study published in the Proceedings ... researcher, James Amos-Landgraf examined a group of male rats ...
    (Date:12/21/2014)... December 21, 2014 The Oncology Institute of ... the Santa Ana and Whittier offices. The Hope for the ... lives of patients and their families during the holiday season. ... to approximately 70 children between both offices. This event continues ... of Target’s community service team, store managers and assistant managers ...
    (Date:12/20/2014)... 21, 2014 BambooIndustry.com is a professional ... . The business has recently shown its new engineered ... all its bamboo flooring models. , BambooIndustry.com’s customers come ... Asia and more. According to the CEO of the ... very fast in the past few years, and the ...
    (Date:12/20/2014)... 21, 2014 MissyDress, a distinguished special ... prom lovers. The business has drastically cut prices to ... to everyone until Jan. 30, 2015. Many of the ... dresses, V-neck dresses, lace dresses, and more. , A ... there every day. Whether A-line princess prom dresses or ...
    Breaking Medicine News(10 mins):Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:MissyDress: The Prices of Prom Dresses Just Reduced 2
    ... For the past 17 months, researchers with the National ... the impact of prolonged operational confinement on the sleep, ... Mars mission simulation in Moscow. The 520-day simulation, which ... Center of the Russian Federation Institute for Biomedical ...
    ... UC Santa Barbara have provided a new twist on ... nature and nurture, in introducing a framework for understanding ... genotypes (nature) can express themselves differently as a function ... issue of the journal Social Psychological and Personality ...
    ... Many complications of diabetes, including kidney disease, foot problems ... disease,s impact on the brain is often overlooked. ... Beth Israel Deaconess Medical Center (BIDMC) neurophysiologist Vera Novak, ... on cognitive health in older individuals and has determined ...
    ... , TUESDAY, Nov. 8 (HealthDay News) -- New research finds ... cancer than younger women, suggesting that older patients may not ... made over the past three decades. Researchers analyzed U.S. ... cancer death rates were stable throughout the 1980s for women ...
    ... research have been published in the online version of the ... of the print edition of the journal. The JCO is ... (ASCO), the world,s leading professional society representing physicians who treat ... most common cancer in the US. Over 100,000 patients are ...
    ... are more likely than their male counterparts to suffer from ... national study led by George Mason University researcher Lisa Lindley. ... and be victimized, the research finds. "Why?" Lindley wonders. ... "Bisexuals are often invisible," she says of bisexual women. "There,s ...
    Cached Medicine News:Health News:US institute wraps up data collection in Russian Mars 520-day mission simulation 2Health News:US institute wraps up data collection in Russian Mars 520-day mission simulation 3Health News:UCSB psychology professors study gene-culture interaction 2Health News:UCSB psychology professors study gene-culture interaction 3Health News:Researchers identify diabetes link to cognitive impairment in older adults 2Health News:Researchers identify diabetes link to cognitive impairment in older adults 3Health News:Advances in Breast Cancer Care May Not Be Reaching Older Women 2Health News:Northern Ireland company makes major breakthrough in cancer treatment 2Health News:Bisexual women, more likely than bisexual men, to be depressed and abuse alcohol, new study finds 2
    BD Vacutainer® Specialty Tubes - Trace Element - Plastic...
    Inquire...
    VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
    BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
    Medicine Products: